CR

CRISM Therapeutics Corporation

Overview

Corporate Details

ISIN(s):
VGG042401262
LEI:
213800XFW6MKVCHHPW88
Country:
Virgin Islands (British)
Address:
C/O MAPLES FINANCE BVI LIMITED, VG1110 ROAD TOWN
Sector:
Health Care
Industry:
Biotechnology

Description

No description available.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-03 08:00
Share Issue/Capital Change
Result of Retail Offer and Additional Placing
English 16.8 KB
2025-07-01 17:41
Investor Presentation
Update presentation on the IMC platform
English 14.9 KB
2025-06-30 08:01
Share Issue/Capital Change
Retail Offer
English 39.0 KB
2025-06-30 08:00
Share Issue/Capital Change
Placing
English 58.0 KB
2025-03-31 08:00
Business and Financial Review
Clinical Trial Update
English 17.3 KB
2025-03-27 08:00
Regulatory News Service
Innovate UK Grant Award
English 20.3 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Nanobiotix Logo Nanobiotix France NANO
Nanoform Finland OYJ Logo Nanoform Finland OYJ Finland NANOFH
NanoGroup S.A. Logo NanoGroup S.A. Poland NNG
Nattaro Labs AB Logo Nattaro Labs AB Sweden NATTA
Neovacs Logo Neovacs France ALNEV
Newron Pharmaceuticals S.p.A. Logo Newron Pharmaceuticals S.p.A. Italy NWRN
NextCell Pharma AB Logo NextCell Pharma AB Sweden NXTCL
NextFerm Technologies Ltd. Logo NextFerm Technologies Ltd. Israel NXFR
NFL Biosciences Logo NFL Biosciences France ALNFL
Nortem BioGroup Logo Nortem BioGroup Spain MLBIO